Countagen

Countagen is a company that specializes in developing reagent kits for genomic research. Their GeneAbacus kits, developed using proprietary Countagen technology, are made-to-order and simple-to-use kits for analyzing the efficiency and specificity of CRISPR-based editing techniques. These kits enable researchers to reliably count and identify gene edits, providing quantitative and actionable data. Countagen's technology, called Countagen technology, eliminates the risk of amplification bias or cross-contamination and allows for the precise quantification of gene editing efficiency and identification of desired mutations. The company aims to accelerate genomic research and offer quicker screening possibilities for researchers. Countagen's technology could be particularly useful for laboratories performing routine genotyping, making CRISPR-based gene modifications, or optimizing multiplexed amplicon sequencing.